FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers Meeting Abstract
| Authors: | Schreck, K. C.; De La Fuente, M. I.; Rine, J.; Kline, I.; Shephard, S. P.; Ahnert, J. R.; Sherman, E. J.; Yaeger, R. |
| Abstract Title: | FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2025 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-01 |
| Start Page: | TPS2091 |
| Language: | English |
| ACCESSION: | WOS:001509513000001 |
| DOI: | 10.1200/JCO.2025.43.16_suppl.TPS2091 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
